Biomea Fusion To Participate In Upcoming Investor Events

Biomea Fusion To Participate In Upcoming Investor Events

REDWOOD CITY, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a biopharmaceutical company focused on the......

Agios to Participate in March Investor Conferences

Agios to Participate in March Investor Conferences

CAMBRIDGE, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism pioneering......

German American Bank announces Michael F. Beckwith as Chief

German American Bank announces Michael F. Beckwith as Chief

JASPER, Ind., March 02, 2023 (GLOBE NEWSWIRE) -- German American Bancorp, Inc. (NASDAQ: GABC) and its banking subsidiary, German American Bank, announces......

Aerovate Therapeutics to Present at Cowen 43rd Annual

Aerovate Therapeutics to Present at Cowen 43rd Annual

WALTHAM, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on......

Homology Medicines to Participate in the 43rd Annual Cowen

Homology Medicines to Participate in the 43rd Annual Cowen

BEDFORD, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Albert......

Medicenna to Present at the Oppenheimer 33rd Annual

Medicenna to Present at the Oppenheimer 33rd Annual

TORONTO and HOUSTON, March 02, 2023 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA), a......

Pharvaris to Present in Upcoming March Investor

Pharvaris to Present in Upcoming March Investor

ZUG, Switzerland, March 02, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor......

Lands' End Announces Fourth Quarter and Fiscal 2022

Lands' End Announces Fourth Quarter and Fiscal 2022

DODGEVILLE, Wis., March 02, 2023 (GLOBE NEWSWIRE) -- Lands' End, Inc. (NASDAQ: LE) will host a conference call at 8:30 a.m. Eastern Time on Thursday,......

Cerevel Therapeutics to Present at the 43rd Annual Cowen

Cerevel Therapeutics to Present at the 43rd Annual Cowen

CAMBRIDGE, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain......

Great Elm Capital Corp. Announces Fourth Quarter and Full

Great Elm Capital Corp. Announces Fourth Quarter and Full

Company to Host Conference Call and Webcast at 8:30 AM ET Today......

  • 1
  • ...
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • ...
  • 44
  • menu
    menu